0,808  0,010  Caspase 9 stimulant
0,749  0,005  5 Hydroxytryptamine release stimulant
0,665  0,005  CYP2C19 inhibitor
0,671  0,012  Respiratory analeptic
0,678  0,021  Antineoplastic (lung cancer)
0,651  0,005  Cardiodepressant
0,645  0,009  Spasmolytic
0,590  0,005  Muscle relaxant
0,585  0,004  Alpha 2 adrenoreceptor antagonist
0,582  0,008  CYP2D6 inhibitor
0,575  0,005  5 Hydroxytryptamine antagonist
0,569  0,004  Skeletal muscle relaxant
0,563  0,005  Alpha adrenoreceptor antagonist
0,573  0,019  Antidepressant
0,569  0,021  Mood disorders treatment
0,555  0,014  Caspase 3 stimulant
0,547  0,007  Sedative
0,560  0,028  Antineoplastic (colorectal cancer)
0,556  0,026  Antineoplastic (colon cancer)
0,540  0,014  Antineoplastic (non-small cell lung cancer)
0,528  0,007  Sigma receptor agonist
0,518  0,004  Neurotrophic factor enhancer
0,506  0,013  Antineoplastic (glioblastoma multiforme)
0,494  0,006  5 Hydroxytryptamine 2 antagonist
0,533  0,047  Antineoplastic (breast cancer)
0,538  0,063  Apoptosis agonist
0,478  0,004  Dopamine D1 antagonist
0,493  0,020  Antineoplastic (glioma)
0,501  0,028  Histamine release inhibitor
0,462  0,006  Dopamine antagonist
0,468  0,028  CYP1A2 substrate
0,445  0,005  5 Hydroxytryptamine 2A antagonist
0,474  0,037  Prostate cancer treatment
0,463  0,032  Antineoplastic (ovarian cancer)
0,457  0,027  Analeptic
0,434  0,012  Cyclic AMP phosphodiesterase inhibitor
0,419  0,005  Alpha 2b adrenoreceptor antagonist
0,460  0,048  Antileukemic
0,440  0,030  Antineoplastic (brain cancer)
0,414  0,007  Dopamine D2 antagonist
0,407  0,005  Alpha 2a adrenoreceptor antagonist
0,469  0,069  Antineoplastic (solid tumors)
0,421  0,028  Antineoplastic (multiple myeloma)
0,403  0,011  Antineoplastic (squamous cell carcinoma)
0,420  0,036  Antineoplastic (melanoma)
0,397  0,017  P-glycoprotein inhibitor
0,407  0,029  CYP1A2 inhibitor
0,373  0,004  Dopamine D3 antagonist
0,391  0,024  Antimitotic
0,390  0,031  DNA damaging
0,366  0,010  5 Hydroxytryptamine 2B antagonist
0,400  0,044  Hepatic disorders treatment
0,389  0,035  CYP3A4 inhibitor
0,357  0,008  Alpha 1 adrenoreceptor antagonist
0,356  0,013  Cholinergic
0,354  0,014  Tubulin antagonist
0,350  0,016  Male reproductive disfunction treatment
0,341  0,010  Acetylcholinesterase inhibitor
0,355  0,023  Antiparkinsonian, rigidity relieving
0,361  0,033  Antineoplastic (renal cancer)
0,374  0,050  CYP2D6 substrate
0,345  0,026  Abortion inducer
0,319  0,005  Phobic disorders treatment
0,364  0,050  Antiischemic
0,361  0,050  Vasodilator, coronary
0,359  0,049  Antineoplastic (pancreatic cancer)
0,391  0,082  Antiparkinsonian
0,325  0,017  5 Hydroxytryptamine 1E antagonist
0,322  0,019  Antineoplastic (carcinoma)
0,341  0,045  NOS2 expression inhibitor
0,319  0,025  Hepatoprotectant
0,363  0,073  CYP3A4 substrate
0,297  0,007  Breast cancer-resistant protein inhibitor
0,296  0,007  Alpha 2c adrenoreceptor antagonist
0,306  0,017  Antiischemic, cerebral
0,300  0,011  Topoisomerase I inhibitor
0,297  0,010  Heat shock protein 90 antagonist
0,296  0,015  Acetylcholine M1 receptor antagonist
0,291  0,014  Antiadrenergic
0,365  0,091  15-Lipoxygenase inhibitor
0,287  0,014  Adrenaline antagonist
0,288  0,019  Topoisomerase II inhibitor
0,312  0,054  Antineoplastic (cervical cancer)
0,268  0,012  Uterine stimulant
0,315  0,059  Hypoxia-inducible factor 1 alpha inhibitor
0,270  0,014  LDLR expression enhancer
0,322  0,068  Anxiolytic
0,315  0,061  Antineoplastic (small cell lung cancer)
0,264  0,010  5 Hydroxytryptamine 1A antagonist
0,334  0,082  Transcription factor NF kappa B inhibitor
0,262  0,012  5 Hydroxytryptamine 1 antagonist
0,272  0,024  MAO inhibitor
0,315  0,071  12-Lipoxygenase inhibitor
0,259  0,025  Antiparkinsonian, tremor relieving
0,245  0,015  Butyrylcholinesterase inhibitor
0,322  0,093  CYP2C9 substrate
0,238  0,009  Calcium antagonist
0,278  0,051  Antineoplastic (sarcoma)
0,298  0,072  Antipsychotic
0,332  0,110  TNF expression inhibitor
0,229  0,007  Antineoplastic alkaloid
0,241  0,029  Lipid peroxidase inhibitor
0,239  0,027  Erectile dysfunction treatment
0,233  0,023  MAO A inhibitor
0,259  0,050  Antineoplastic enhancer
0,223  0,014  Alpha 1a adrenoreceptor antagonist
0,212  0,003  Heat shock protein 90 beta antagonist
0,211  0,005  Acetylcholine M4 receptor antagonist
0,226  0,027  Genotoxic
0,254  0,057  Psychostimulant
0,200  0,007  CDC-like kinase 3 inhibitor
0,261  0,069  Antineoplastic (bladder cancer)
0,253  0,070  Antineoplastic (liver cancer)
0,299  0,117  CYP2C9 inhibitor
0,206  0,024  DNA intercalator
0,205  0,024  MAO B inhibitor
0,210  0,031  CDC-like kinase 1 inhibitor
0,186  0,007  Alpha tubulin antagonist
0,228  0,052  Pneumotoxic
0,244  0,069  Antineoplastic (lymphoma)
0,231  0,057  Nitric oxide antagonist
0,213  0,042  Heat shock protein 90 alpha antagonist
0,207  0,038  Toxic, respiratory center
0,276  0,110  Vasodilator, peripheral
0,240  0,074  Antineoplastic (lymphocytic leukemia)
0,173  0,008  Phosphodiesterase V inhibitor
0,210  0,046  UGT1A3 substrate
0,191  0,027  Acetylcholine muscarinic antagonist
0,252  0,091  CYP2C19 substrate
0,221  0,059  Chemopreventive
0,170  0,010  Beta tubulin antagonist
0,245  0,086  UGT1A9 substrate
0,243  0,087  Antioxidant
0,187  0,034  Acetylcholine antagonist
0,188  0,035  Cholinergic antagonist
0,159  0,009  Phosphodiesterase 5A inhibitor
0,159  0,012  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,154  0,009  Phosphodiesterase 11A inhibitor
0,154  0,009  Phosphodiesterase XI inhibitor
0,201  0,061  5 Hydroxytryptamine 3E antagonist
0,226  0,092  Aldehyde oxidase inhibitor
0,170  0,043  Bipolar disorder treatment
0,163  0,038  Antitussive
0,200  0,076  Antiarrhythmic
0,163  0,039  Antiviral (Hepatitis B)
0,177  0,054  Melanin inhibitor
0,205  0,083  VCAM1 expression inhibitor
0,201  0,080  Pyruvate kinase inhibitor
0,145  0,024  Topoisomerase II alpha inhibitor
0,300  0,180  MAP kinase 1 inhibitor
0,255  0,135  Antiprotozoal (Plasmodium)
0,167  0,047  Antifungal enhancer
0,146  0,027  Dementia treatment
0,190  0,072  VEGF expression inhibitor
0,215  0,096  Tumour necrosis factor alpha release inhibitor
0,196  0,080  Amyloid beta aggregation inhibitor
0,141  0,027  Vascular dementia treatment
0,133  0,019  Dopamine D4 antagonist
0,205  0,092  RNA-directed DNA polymerase inhibitor
0,115  0,004  Ryanodine receptor antagonist
0,168  0,059  Carcinogenic, group 1
0,208  0,102  Myocardial infarction treatment
0,135  0,031  5 Hydroxytryptamine 2C antagonist
0,120  0,016  Acetylcholine M2 receptor antagonist
0,154  0,052  NADPH oxidase inhibitor
0,115  0,014  Acetylcholine M5 receptor antagonist
0,172  0,073  Antineoplastic (bone cancer)
0,104  0,006  5 Hydroxytryptamine 7 agonist
0,110  0,015  Acetylcholine M5 receptor agonist
0,182  0,092  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,099  0,011  Glutamate (mGluR7) antagonist
0,110  0,023  5 Hydroxytryptamine uptake inhibitor
0,136  0,051  Antineoplastic (uterine cancer)
0,164  0,080  Liver fibrosis treatment
0,172  0,087  Platelet adhesion inhibitor
0,124  0,041  DOPA decarboxylase inhibitor
0,103  0,027  Alpha adrenoreceptor agonist
0,122  0,046  Multidrug resistance-associated protein 1 inhibitor
0,099  0,024  5 Hydroxytryptamine 1B antagonist
0,093  0,018  5 Hydroxytryptamine 5A antagonist
0,142  0,068  Toll-Like receptor 9 antagonist
0,132  0,057  Papain-like protease (SARS coronavirus) inhibitor
0,108  0,035  Restless leg syndrome treatment
0,122  0,051  Sphingosine 1-phosphate receptor 2 agonist
0,082  0,012  Dopamine D5 antagonist
0,202  0,132  Tyrosine 3 hydroxylase inhibitor
0,104  0,034  ATPase (Vacuolar H+) inhibitor
0,125  0,057  Menstruation disorders treatment
0,185  0,117  Vasodilator
0,158  0,091  Tumour necrosis factor antagonist
0,183  0,118  Cytostatic
0,085  0,019  5 Hydroxytryptamine 5 antagonist
0,086  0,021  Alpha 1 adrenoreceptor agonist
0,092  0,026  Phosphodiesterase VI inhibitor
0,099  0,034  5 Hydroxytryptamine agonist
0,096  0,032  Glutamate decarboxylase inhibitor
0,155  0,091  UGT2B10 substrate
0,138  0,077  Protein kinase stimulant
0,228  0,170  Cognition disorders treatment
0,175  0,117  Antiprotozoal (Leishmania)
0,080  0,024  Alpha 2 adrenoreceptor agonist
0,169  0,115  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,161  0,108  DNA methylase inhibitor
0,162  0,111  CYP2B6 inhibitor
0,073  0,023  Melanin-concentrating hormone receptor 1 antagonist
0,152  0,104  Cytotoxic
0,139  0,091  Thrombolytic
0,077  0,034  Female sexual dysfunction treatment
0,101  0,058  Obsessive-compulsive disorder treatment
0,069  0,027  Postmenopausal disorders treatment
0,072  0,030  Acetylcholine M3 receptor antagonist
0,127  0,085  Attention deficit/hyperactivity disorder treatment
0,163  0,121  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,128  0,087  UGT2B15 substrate
0,086  0,046  T cell inhibitor
0,154  0,114  UGT1A1 substrate
0,080  0,041  Antitreponemal
0,097  0,058  Phosphodiesterase 6D inhibitor
0,083  0,044  Alpha 1b adrenoreceptor antagonist
0,048  0,011  Endothelin receptor antagonist
0,184  0,147  DNA synthesis inhibitor
0,115  0,079  Contraceptive female
0,072  0,036  5 Hydroxytryptamine 7 antagonist
0,112  0,076  Alkylator
0,052  0,017  Phosphodiesterase 6C inhibitor
0,083  0,047  Nicotinic alpha4beta2 receptor antagonist
0,133  0,099  UGT1A4 substrate
0,048  0,014  Vesicle monoamine transporter inhibitor
0,060  0,026  5 Hydroxytryptamine 2 agonist
0,081  0,048  Focal adhesion kinase 1 inhibitor
0,155  0,122  Antihypertriglyceridemic
0,148  0,116  Anesthetic general
0,055  0,024  Factor III inhibitor
0,038  0,007  Endothelin B receptor antagonist
0,070  0,039  5 Hydroxytryptamine 1D antagonist
0,098  0,068  Estrogen receptor beta antagonist
0,105  0,075  Interleukin 1b antagonist
0,079  0,048  MAP kinase 7 inhibitor
0,175  0,145  Cardiotonic
0,090  0,061  Antiviral (Hepatitis A)
0,062  0,034  Bcl-xL inhibitor
0,107  0,079  Microtubule formation inhibitor
0,136  0,109  Cystic fibrosis treatment
0,193  0,167  5 Hydroxytryptamine uptake stimulant
0,062  0,037  Potassium channel (Ca-activated) blocker
0,035  0,011  Dopamine autoreceptor agonist
0,067  0,046  Dopamine agonist
0,158  0,138  Antihypercholesterolemic
0,197  0,177  ICAM1 expression inhibitor
0,135  0,115  Sensitization
0,085  0,066  Phosphodiesterase I inhibitor
0,124  0,105  Antiviral (Herpes)
0,029  0,010  Endothelin A receptor antagonist
0,114  0,097  Antihemorrhagic
0,053  0,036  5 Hydroxytryptamine 1B agonist
0,132  0,116  Myocardial ischemia treatment
0,099  0,084  Electron transport complex I inhibitor
0,111  0,096  Antiviral (Papilloma)
0,138  0,123  ATPase inhibitor
0,140  0,124  Clk dual-specificity kinase inhibitor
0,110  0,095  DNA repair enzyme inhibitor
0,056  0,041  5 Hydroxytryptamine 6 antagonist
0,104  0,089  Estrogen antagonist
0,041  0,027  Acid-sensing ion channel blocker
0,107  0,093  CNS active muscle relaxant
0,150  0,136  Dyrk kinase inhibitor
0,032  0,019  Phosphodiesterase 6B inhibitor
0,216  0,202  Antiprotozoal
0,177  0,164  Radiosensitizer
0,108  0,095  Contraceptive
0,056  0,044  Alpha 1d adrenoreceptor antagonist
0,192  0,180  Thioredoxin glutathione reductase inhibitor
0,055  0,044  Dopamine uptake inhibitor
0,024  0,016  Phosphodiesterase 6G inhibitor
0,024  0,016  Phosphodiesterase 6H inhibitor
0,056  0,049  Adrenaline uptake inhibitor
0,040  0,034  Dopamine D2 agonist
0,099  0,093  Antiseptic
0,170  0,165  Proliferative diseases treatment
0,104  0,101  Phosphodiesterase inhibitor
0,153  0,150  Antipyretic
0,137  0,135  Non-steroidal antiinflammatory agent
0,150  0,148  Antiamyloidogenic
0,070  0,068  Narcotic antagonist
0,110  0,109  Activin receptor-like kinase 2 inhibitor
0,070  0,069  Acetylcholine nicotinic antagonist
0,048  0,048  Nicotinic alpha3beta2 receptor antagonist
0,030  0,029  Melatonin 1 agonist

